Microbial transglutaminases generate T cell stimulatory epitopes involved in celiac disease

Journal of Cereal Science

Volumn 47, Issue 2, 2008, Pages 339-346

  Dekking, E H A ^a   Van Veelen, P A ^a   de Ru, A ^a   Kooy Winkelaar, E M C ^a   Groneveld T ^b   Nieuwenhuizen, W F ^b,c   Koning, F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c NUMICO RESEARCH   (Netherlands)

Author keywords

Celiac disease; Gluten; Microbial transglutaminase; T cell stimulatory epitopes; Tissue transglutaminase

Indexed keywords

EID: 39649089846     PISSN: 07335210     EISSN: 10959963     Source Type: Journal    
DOI: 10.1016/j.jcs.2007.05.004     Document Type: Article

References (31)

1. Anderson R.P., Degano P., Godkin A.J., Jewell D.P., and Hill A.V. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nature Medicine 66 (2000) 337-342
2. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y.M., Lundin K.E., Koning F., Roepstorff P., et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. The Journal of Experimental Medicine 191 (2000) 603-612
3. Arentz-Hansen H., McAdam S.N., Molberg O., Fleckenstein B., Lundin K.E., Jorgensen T.J., Jung G., Roepstorff P., and Sollid L.M. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 123 (2002) 803-809
4. Bruce S.E., Bjarnason I., and Peters T.J. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clinical Science (Colch) 68 (1985) 573-579
5. Catassi C., Rossini M., Ratsch I.M., Bearzi I., Santinelli A., Castagnani R., Pisani E., Coppa G.V., and Giorgi P.L. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34 (1993) 1515-1519
6. Catassi C., Ratsch I.M., Fabiani E., Rossini M., Bordicchia F., Candela F., Coppa G.V., and Giorgi P.L. Coeliac disease in the year 2000: exploring the iceberg. Lancet 343 (1994) 200-203
7. Catassi C., Fabiani E., Iacono G., D'Agate C., Francavilla R., Biagi F., Volta U., Accomando S., Picarelli A., De Vitis I., Pianelli G., Gesuita R., Carle F., Mandolesi A., Bearzi I., and Fasano A. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. The American Journal of Clinical Nutrition 85 (2007) 160-166
8. Ciacci C., and Mazzacca G. Unintentional gluten ingestion in celiac patients. Gastroenterology 115 (1998) 243
9. Corrao G., Corazza G.R., Bagnardi V., Brusco G., Ciacci C., Cottone M., Guidetti C.S., Usai P., Cesari P., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358 (2001) 356-361
10. Csizmadia C.G., Mearin M.L., von Blomberg B.M., Brand R., and Verloove-Vanhorick S.P. An iceberg of childhood coeliac disease in the Netherlands. Lancet 353 (1999) 813-814
11. Fasano A., Berti I., Gerarduzzi T., Not T., Colletti R.B., Drago S., Elitsur Y., Green P.H., Guandalini S., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Archives of Internal Medicine 163 (2003) 286-292
12. Gerrard J.A., Newberry M.P., Ross M., Wilson A.J., Fayle S.E., and Kavale S. Pastry lift and croissant volume as affected by microbial transglutaminase. Journal of Food Science 65 (2001) 312-314
13. Hischenhuber C., Crevel R., Jarry B., Maki M., Moneret-Vautrin D.A., Romano A., Troncone R., and Ward R. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Alimentary Pharmacology & Therapeutics 23 (2006) 559-575
14. Kim C.Y., Quarsten H., Bergseng E., Khosla C., and Sollid L.M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 4175-4179
15. Kwok W.W., Domeier M.L., Raymond F.C., Byers P., and Nepom G.T. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. Journal of Immunology 156 (1996) 2171-2177
16. Molberg O., McAdam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Noren O., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine 4 (1998) 713-717
17. Molberg O., Solheim F.N., Jensen T., Lundin K.E., Arentz-Hansen H., Anderson O.D., Kjersti U.A., and Sollid L.M. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 125 (2003) 337-344
18. Ohtsuka T., Sawa A., Kawabata R., Nio N., and Motoki M. Substrate specificities of microbial transglutaminases for primary amines. Journal of Agricultural Food Chemistry 48 (2000) 6230-6233
19. Pedersen M.H., Hansen T.K., Sten E., Seguro K., Ohtsuka T., Morita A., Bindslev-Jensen C., and Poulsen L.K. Evaluation of the potential allergenicity of the enzyme microbial transglutaminase using the 2001 FAO/WHO Decision Tree. Molecular Nutrition & Food Research 48 (2004) 434-440
20. Rostami K., Mulder C.J., Were J.M., van Beukelen F.R., Kerchhaert J., Crusius J.B., Pena A.S., Willekens F.L., and Meijer J.W. High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scandinavian Journal of Gastroenterology 34 (1999) 276-279
21. Sato H., Hayashi E., Yamada, Yatagai M., and Takahara Y. Further studies on the site-specific protein modification by microbial transglutaminase. Bioconjugate Chemistry 12 (2001) 701-710
22. Sjostrom H., Lundin K.E., Molberg O., Korner R., McAdam S.N., Anthonsen D., Quarsten H., Noren O., Roepstorff P., et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scandinavian Journal of Immunology 48 (1998) 111-115
23. Vader W., Kooy Y., van Veelen P., De Ru A., Harris D., Benckhuijsen W., Pena S., Mearin L., Drijfhout J.W., and Koning F. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122 (2002) 1729-1737
24. Vader L.W., De Ru A., van der Wal Y., Kooy Y.M., Benckhuijsen W., Mearin M.L., Drijfhout J.W., van Veelen P., and Koning F. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. The Journal of Experimental Medicine 195 (2002) 643-649
25. Van de Wal Y., Kooy Y.M.C., Drijfhout J.W., Amons R., and Koning F. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics 44 (1996) 246-253
26. Van de Wal Y., Kooy Y.M., van Veelen P.A., Pena S.A., Mearin L.M., Molberg O., Lundin K.E., Sollid L.M., Mutis T., et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 10050-10054
27. Van de Wal Y., Kooy Y., van Veelen P., Pena S., Mearin L., Papadopoulos G., and Koning F. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. Journal of Immunology 15 161 (1998) 1585-1588
28. Van de Wal Y., Kooy Y.M., van Veelen P., Vader W., August S.A., Drijfhout J.W., Pena S.A., and Koning F. Glutenin is involved in the gluten-driven mucosal T cell response. European Journal of Immunology 29 (1999) 3133-3139
29. Vartdal F., Johansen B.H., Friede T., Thorpe C.J., Stevanovic S., Eriksen J.E., Sletten K., Thorsby E., Rammensee H.G., and Sollid L.M. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. European Journal of Immunology 26 (1996) 2764-2772
30. Zhu Y., Rinzema A., and Tramper J. Microbial transglutaminase-a review of its production and application in food processing. Applications in Microbiological Biotechnology 44 (1995) 227-282
31. Zhu Y., Rinzema A., Tramper J., De Bruin E., and Bol J. Fed-batch fermentation dealing with nitrogen limitation in microbial transglutaminase production by Streptoverticillium mobaraense. Applications in Microbiological Biotechnology 49 (1998) 251-257